The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
By A. Ross, JoAnn E. Manson, S. Abrams, J. Aloia, P. Brannon, S. Clinton, R. Durazo-Arvizu, J. Gallagher, R. Gallo, Glenville Jones and 4 more. Journal of Clinical Endocrinology and Metabolism, 2010
4,028 citations recorded by the source corpus.
This article summarizes the new 2011 report on dietary requirements for calcium and vitamin D from the Institute of Medicine (IOM). An IOM Committee charged with determining the population needs for these nutrients in North America conducted a comprehensive review of the evidence for both skeletal and extraskeletal outcomes. The Committee concluded that available scientific evidence supports a key role of calcium and vitamin D in skeletal health, consistent with a cause-and-effect relationship and providing a sound basis for determination of intake requirements. For extraskeletal outcomes, including cancer, cardiovascular disease, diabetes, and autoimmune disorders, the evidence was inconsistent, inconclusive as to causality, and insufficient to inform nutritional requirements. Randomized clinical trial evidence for extraskeletal outcomes was limited and generally uninformative. Based on bone health, Recommended Dietary Allowances (RDAs; covering requirements of ≥97.5% of the population) for calcium range from 700 to 1300 mg/d for life-stage groups at least 1 yr of age. For vitamin D, RDAs of 600 IU/d for ages 1–70 yr and 800 IU/d for ages 71 yr and older, corresponding to a serum 25-hydroxyvitamin D level of at least 20 ng/ml (50 nmol/liter), meet the requirements of at least 97.5% of the population. RDAs for vitamin D were derived based on conditions of minimal sun exposure due to wide variability in vitamin D synthesis from ultraviolet light and the risks of skin cancer. Higher values were not consistently associated with greater benefit, and for some outcomes U-shaped associations were observed, with risks at both low and high levels. The Committee concluded that the prevalence of vitamin D inadequacy in North America has been overestimated. Urgent research and clinical priorities were identified, including reassessment of laboratory ranges for 25-hydroxyvitamin D, to avoid problems of both undertreatment and overtreatment.
Subfields: Orthopedics and Sports Medicine, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/09f638cea0973d3faaacb81952440572423cbdd6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Orthopedics and Sports Medicine
In Pathology and Forensic Medicine
In Public Health, Environmental and Occupational Health
Citations in the corpus
- The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. (2012, methodology): “D in response to sun), and diet or supplement-taking practices (3, 135, 163).”
- Vitamin D deficiency 2.0: an update on the current status worldwide (2020, background): “While the upper daily limit given by the Endocrine Society is 10,000 IU [12] , the IOM and The European Food and Safety Authority recommend staying below 4000 IU/day (100 µg) [37, 38] .”
- Global Consensus Recommendations on Prevention and Management of Nutritional Rickets (2016, background): “(1 ⨁ ⨁ ⨁ ) • Beyond 12 months of age, all children and adults need to meet their nutritional requirement for vitamin D through diet and/or supplementation, which is at least 600 IU/day (15 μg), as recommended by the Institute of Medicine (IOM).”
- Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies (2012, result): “a closer investigation of prior studies indicates that the association between 25(OH)-vitamin D and CVD risk may be nonlinear and reach a plateau between 50 and 75 nmol/L.(19) Others have suggested a possible U-shaped relation, with a slight increase in CVD risk at both low (<50 nmol/L) and high (>1”
- The clinician’s guide to prevention and treatment of osteoporosis (2022, background): “Table 10 Recommended calcium and vitamin D intakes for women and men [2, 94].”
- Vitamin D supplementation guidelines. (2018, background): “The IOM guidelines were commissioned by the United States and Canadian Governments for public health purposes and not to use as clinical practice guidance, for the population living in North America [19].”